Novacyt S.A.

ENXTPA:ALNOV Stock Report

Market Cap: €32.3m

Novacyt Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Lyn Rees

Chief executive officer

UK£336.1k

Total compensation

CEO salary percentage31.05%
CEO tenure1yr
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenure1.5yrs

Recent management updates

Recent updates

There's No Escaping Novacyt S.A.'s (EPA:ALNOV) Muted Revenues

Jan 09
There's No Escaping Novacyt S.A.'s (EPA:ALNOV) Muted Revenues

Novacyt S.A. (EPA:ALNOV) Not Doing Enough For Some Investors As Its Shares Slump 36%

Sep 30
Novacyt S.A. (EPA:ALNOV) Not Doing Enough For Some Investors As Its Shares Slump 36%

Novacyt S.A. (EPA:ALNOV) Stock Catapults 39% Though Its Price And Business Still Lag The Industry

Aug 16
Novacyt S.A. (EPA:ALNOV) Stock Catapults 39% Though Its Price And Business Still Lag The Industry

Here's Why Novacyt (EPA:ALNOV) Must Use Its Cash Wisely

Aug 15
Here's Why Novacyt (EPA:ALNOV) Must Use Its Cash Wisely

Revenues Working Against Novacyt S.A.'s (EPA:ALNOV) Share Price

Jun 14
Revenues Working Against Novacyt S.A.'s (EPA:ALNOV) Share Price

Is Novacyt (EPA:ALNOV) In A Good Position To Deliver On Growth Plans?

Nov 28
Is Novacyt (EPA:ALNOV) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Novacyt's (EPA:ALNOV) Cash Burn Rate

Jul 04
We're Keeping An Eye On Novacyt's (EPA:ALNOV) Cash Burn Rate

Estimating The Fair Value Of Novacyt S.A. (EPA:ALNOV)

Jan 24
Estimating The Fair Value Of Novacyt S.A. (EPA:ALNOV)

With EPS Growth And More, Novacyt (EPA:ALNOV) Is Interesting

Mar 18
With EPS Growth And More, Novacyt (EPA:ALNOV) Is Interesting

With EPS Growth And More, Novacyt (EPA:ALNOV) Is Interesting

Nov 25
With EPS Growth And More, Novacyt (EPA:ALNOV) Is Interesting

Little Excitement Around Novacyt S.A.'s (EPA:ALNOV) Earnings As Shares Take 25% Pounding

Sep 29
Little Excitement Around Novacyt S.A.'s (EPA:ALNOV) Earnings As Shares Take 25% Pounding

Novacyt's (EPA:ALNOV) Wonderful 999% Share Price Increase Shows How Capitalism Can Build Wealth

Mar 08
Novacyt's (EPA:ALNOV) Wonderful 999% Share Price Increase Shows How Capitalism Can Build Wealth

Is Novacyt S.A.'s(EPA:ALNOV) Recent Stock Performance Tethered To Its Strong Fundamentals?

Jan 22
Is Novacyt S.A.'s(EPA:ALNOV) Recent Stock Performance Tethered To Its Strong Fundamentals?

Calculating The Intrinsic Value Of Novacyt S.A. (EPA:ALNOV)

Dec 15
Calculating The Intrinsic Value Of Novacyt S.A. (EPA:ALNOV)

We're Not Counting On Novacyt (EPA:ALNOV) To Sustain Its Statutory Profitability

Nov 19
We're Not Counting On Novacyt (EPA:ALNOV) To Sustain Its Statutory Profitability

CEO Compensation Analysis

How has Lyn Rees's remuneration changed compared to Novacyt's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

-UK£39m

Jun 30 2024n/an/a

-UK£37m

Mar 31 2024n/an/a

-UK£33m

Dec 31 2023UK£336kUK£104k

-UK£24m

Compensation vs Market: Lyn's total compensation ($USD450.99K) is above average for companies of similar size in the French market ($USD313.05K).

Compensation vs Earnings: Insufficient data to compare Lyn's compensation with company performance.

CEO

Lyn Rees (51 yo)

1yr
Tenure
UK£336,106
Compensation

Mr. Lyn Dafydd Rees serves as Executive Director at Novacyt S. A. since September 2023 and serves as its Chief Executive Officer since May 01, 2024. He serves as Non-Executive Director at MyHealthChecked P...

Leadership Team

NamePositionTenureCompensationOwnership
Lyn Rees
CEO & Executive Director1yrUK£336.11kno data
Steve Gibson
CFO & Director1.3yrsno datano data
Bryan Close
Chief Operations Officer3.3yrsno datano data
Joanne Mason
Chief Scientific Officer & Director1.3yrsno datano data
David Franks
Chief Human Resources Officer4.1yrsno datano data
Paul Oladimeji
Group Head of R&Dno datano datano data
1.3yrs
Average Tenure

Experienced Management: ALNOV's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Lyn Rees
CEO & Executive Director1.7yrsUK£336.11kno data
Steve Gibson
CFO & Director1.3yrsno datano data
Joanne Mason
Chief Scientific Officer & Director1.3yrsno datano data
John Brown
Non-Executive Chairman1.7yrsUK£15.24kno data
Ian Gilham
Non-Executive Directorless than a yearno datano data
Juliet Thompson
Independent Non-Executive Director7.9yrsUK£48.93kno data
Jean-Pierre Crinelli
Independent Non-Executive Directorno dataUK£34.04kno data
David Gardner
Member of Scientific Committeeno datano datano data
Marco Zonta
Member of Scientific Committeeno datano datano data
Isabelle Cartier
Member of Scientific Committeeno datano datano data
Geneviève Bourg-Heckly
Member of Scientific Committeeno datano datano data
1.5yrs
Average Tenure
58yo
Average Age

Experienced Board: ALNOV's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 01:25
End of Day Share Price 2025/05/22 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Novacyt S.A. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mathieu JasminArkeon Finance
Johann CarrierInvest Securities
Stefan HamillNumis Securities Ltd.